Cue Biopharma Board Sees Four Independent Directors Exit as Company Bolsters Late-Stage Capabilities
Cue Biopharma Inc. (NASDAQ:CUE) experienced a 5.4% decline in after-hours trading following the resignation of four independent board members effective May 29, 2026. The company named two new directors as it refocuses governance to support its transition toward late clinical-stage capabilities. Management described the appointments as adding strate…